Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition). (April 2017) - Jonasova, A.; Neuwirtova, R.; Polackova, H.; Siskova, M.; Tomas, S.; Cmunt, E.; Belickova, M.; Fuchs, O.; Moudra, A.; Michalova, K.; Zemanova, Z.